{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:10Z","timestamp":1793924830870,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jacadv.2026.102742","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:48:03Z","timestamp":1776469683000},"page":"102742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic Atlas of Cardiovascular Diseases"],"prefix":"10.1016","volume":"5","author":[{"given":"Jingjing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1410-7891","authenticated-orcid":false,"given":"Wanshan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.102742_bib1","article-title":"Cardiovascular disease in the Americas: the epidemiology of cardiovascular disease and its risk factors","volume":"42","author":"Joseph","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.jacadv.2026.102742_bib2","series-title":"Cardiovascular diseases (CVDs)","year":"2024"},{"key":"10.1016\/j.jacadv.2026.102742_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12872-025-04814-5","article-title":"Risk of premature cardiovascular disease and all-cause mortality in young adults, association with risk factor prevalence early in life","volume":"25","author":"Zhu","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacadv.2026.102742_bib4","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1007\/s11010-025-05284-1","article-title":"Dysregulated homocysteine metabolism and cardiovascular disease and clinical treatments","volume":"480","author":"Cao","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacadv.2026.102742_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41569-022-00698-6","article-title":"Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer","volume":"19","author":"Karlstaedt","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacadv.2026.102742_bib6","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"Back","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacadv.2026.102742_bib7","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.jacc.2017.09.001","article-title":"How low to Go with glucose, cholesterol, and blood pressure in primary prevention of CVD","volume":"70","author":"Hong","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102742_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000165919","article-title":"The quest for the optimal assessment of global cardiovascular risk: are traditional risk factors and metabolic syndrome partners in crime?","volume":"113","author":"Arsenault","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jacadv.2026.102742_bib9","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.2174\/1568026619666181130140937","article-title":"High throughput metabolomics in clinical studies: review and new applications to remote ischemic preconditioning","volume":"18","author":"Clendenen","year":"2018","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jacadv.2026.102742_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacadv.2026.102742_bib11","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","article-title":"Metabolomic profiles predict individual multidisease outcomes","volume":"28","author":"Buergel","year":"2022","journal-title":"Nature Med"},{"key":"10.1016\/j.jacadv.2026.102742_bib12","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehae244","article-title":"Xylitol is prothrombotic and associated with cardiovascular risk","volume":"45","author":"Witkowski","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.102742_bib13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.031139","article-title":"Functional metabolomics characterizes a key role for N-Acetylneuraminic acid in coronary artery diseases","volume":"137","author":"Zhang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102742_bib14","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European atherosclerosis society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.102742_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12916-018-1240-2","article-title":"NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort","volume":"17","author":"Vignoli","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jacadv.2026.102742_bib16","series-title":"NMR metabolomics","year":"2024"},{"key":"10.1016\/j.jacadv.2026.102742_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12933-024-02439-0","article-title":"Construction of machine learning diagnostic models for cardiovascular pan-disease based on blood routine and biochemical detection data","volume":"23","author":"Wang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacadv.2026.102742_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","article-title":"Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank","volume":"14","author":"Julkunen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacadv.2026.102742_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1213\/ANE.0000000000003424","article-title":"Regression: the apple does not fall far from the tree","volume":"127","author":"Vetter","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacadv.2026.102742_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad002","article-title":"A review on longitudinal data analysis with random forest","volume":"24","author":"Hu","year":"2023","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jacadv.2026.102742_bib21","series-title":"An XGBoost-Based fitted Q iteration for finding the optimal STI strategies for HIV patients","author":"Yu","year":"2022"},{"key":"10.1016\/j.jacadv.2026.102742_bib22","first-page":"2825","article-title":"Scikit-learn: Machine Learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Mach Learn Res"},{"key":"10.1016\/j.jacadv.2026.102742_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.diii.2024.01.008","article-title":"Breast cancer molecular subtype prediction: improving interpretability of complex machine-learning models based on multiparametric-MRI features using SHapley Additive exPlanations (SHAP) methodology","volume":"105","author":"Crombe","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jacadv.2026.102742_bib24","article-title":"Explainable machine learning for predicting 30-day readmission in acute heart failure patients","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jacadv.2026.102742_bib25","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","article-title":"Metabolite profiling identifies pathways associated with metabolic risk in humans","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102742_bib26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbamem.2017.03.013","article-title":"Cardiolipin and mitochondrial cristae organization","volume":"1859","author":"Ikon","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.jacadv.2026.102742_bib27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102742_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/CIRCRESAHA.110.224766","article-title":"The role of endoplasmic reticulum stress in the progression of atherosclerosis","volume":"107","author":"Tabas","year":"2010","journal-title":"Circulation Res"},{"key":"10.1016\/j.jacadv.2026.102742_bib29","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.0000184783.04864.9f","article-title":"Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency","volume":"25","author":"Tabas","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacadv.2026.102742_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jacadv.2026.102742_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S0029665116000070","article-title":"Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from childhood through to adulthood","volume":"75","author":"Connaughton","year":"2016","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.jacadv.2026.102742_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001221","article-title":"A novel protein glycan biomarker and future cardiovascular disease events","volume":"3","author":"Akinkuolie","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2026.102742_bib33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1373\/clinchem.2016.255828","article-title":"Comparison of the predictive value of GlycA and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events","volume":"62","author":"Duprez","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacadv.2026.102742_bib34","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","article-title":"Biomarkers of dietary Omega-6 fatty acids and incident cardiovascular disease and mortality","volume":"139","author":"Marklund","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102742_bib35","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/CIRCULATIONAHA.108.191627","volume":"119","author":"Harris","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102742_bib36","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102742_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacadv.2026.102742_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1370\/afm.983","article-title":"Defining comorbidity: implications for understanding health and health services","volume":"7","author":"Valderas","year":"2009","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jacadv.2026.102742_bib39","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2012.5265","article-title":"Designing health care for the most common chronic condition--multimorbidity","volume":"307","author":"Tinetti","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.102742_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacadv.2026.102742_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jacadv.2026.102742_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibs.2011.09.003","article-title":"The complexity of cardiolipin in health and disease","volume":"37","author":"Claypool","year":"2012","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jacadv.2026.102742_bib43","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacadv.2026.102742_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1373\/clinchem.2011.169573","article-title":"Metabolomics and cardiovascular biomarker discovery","volume":"58","author":"Rhee","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacadv.2026.102742_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","article-title":"The pre-therapeutic classification OF CO-morbidity in chronic disease","volume":"23","author":"Feinstein","year":"1970","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jacadv.2026.102742_bib46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","article-title":"Stroke risk factors, genetics, and prevention","volume":"120","author":"Boehme","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacadv.2026.102742_bib47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O'Donnell","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jacadv.2026.102742_bib48","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2337\/db11-1355","article-title":"Metabolic signatures of insulin resistance in 7,098 young adults","volume":"61","author":"W\u00fcrtz","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jacadv.2026.102742_bib49","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1161\/CIRCULATIONAHA.118.034942","article-title":"Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment","volume":"138","author":"Sliz","year":"2018","journal-title":"Circulation"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26001638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26001638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:54:57Z","timestamp":1793922897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26001638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2772963X26001638"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102742","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic Atlas of Cardiovascular Diseases","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102742"}}